According to a new study published in Journal of the American Medical Association, diabetes drug 'Actos' is not linked to bladder cancer as claimed by some researchers previously. The researchers of Kaiser Permanente Northern California studied data from nearly 2,00,000 diabetes patients and found a link between the use of Actos and a rise in pancreatic cancer risk instead.